Vimarsana
Biggest News Aggregation in the World

Page 13 - Athersys Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Athersys Inc Today - Breaking & Trending Today

Kenneth H. Traub Appointed to Board of American Rare Earths - Vimarsana News

Kenneth H. Traub Appointed to Board of American Rare Earths

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Stem Cell Therapy Market Positioned for Substantial Expansion of USD 921.12 Million by 2030 - Vimarsana News

Stem Cell Therapy Market Positioned for Substantial Expansion of USD 921.12 Million by 2030

The Stem Cell Therapy market research report works as a backbone for the growth of the healthcare industry. Hence the report has been provided with comprehensive market insights and analysis that offer an advanced perspective of the marketplace. The report provides CAGR values along with its fluctuations for the spe...

Athersys prices $3.5 million public offering | Crain's Cleveland Business - Vimarsana News

Athersys prices $3.5 million public offering | Crain's Cleveland Business

Athersys, a Cleveland-based regenerative medicine company, will sell 10.9 million shares of common stock or common stock equivalents at 32 cents per share.

Athersys Reports Second Quarter 2023 Financial Results and Business Highlights - Vimarsana News

Athersys Reports Second Quarter 2023 Financial Results and Business Highlights

16.08.2023 - Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and provided a business ...

Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com - Vimarsana News

Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Trading Down 6.9 % ATHX stock traded down $0.03 during midday trading on Wednesday, hitting $0.39. The stock had a trading volume of […]